Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Twelve patients with severe heterozygous familial hypercholesterolemia, in whom other hypolipidemic drug therapy had failed to reduce serum cholesterol levels to less than 300 mg/dL, were sequentially treated with mevinolin (a specific inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, th...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.7326/0003-4819-101-5-598
データ提供：米国国立医学図書館（NLM）
Treating Severe Familial Hypercholesterolemia: A Quest for Effective Therapies
Familial hypercholesterolemia (FH) is a challenging condition, like a relentless desert wind that carries a heavy burden. This study investigates the use of mevinolin and colestipol, two medications that can help lower cholesterol levels. The authors found that this combination, like a well-stocked caravan, is effective in reducing cholesterol levels, particularly in patients with severe FH who have not responded to other therapies. It's a promising solution, like finding a hidden oasis in the desert, offering relief from a challenging condition.
Navigating the Desert of High Cholesterol
The study demonstrates that combined therapy with mevinolin and colestipol is effective in lowering cholesterol levels in patients with severe FH. This is like finding a reliable source of water in a dry desert, providing a lasting solution for a persistent problem. The researchers found that this approach significantly reduced LDL cholesterol levels, offering a crucial step toward managing this challenging condition.
Managing Cholesterol Levels: A Crucial Step Toward Better Health
The study's findings highlight the importance of finding effective treatments for FH, like finding a path through a treacherous desert landscape. By successfully reducing cholesterol levels, these medications can help prevent heart disease and improve overall health. This research is a reminder that even in the face of challenging conditions, there is hope for better health and a brighter future.
Dr.Camel's Conclusion
This study provides a valuable insight into the management of severe FH, demonstrating the effectiveness of combined therapy with mevinolin and colestipol. It's like finding a new oasis in the desert of high cholesterol, offering a promising avenue for improved health and wellbeing. This research is a testament to the ongoing quest for better treatments for challenging medical conditions.
Date :
- Date Completed 1984-11-14
- Date Revised 2019-06-19
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.